trying to short the stock, figuring we will all sell our holdings and run. ABT, IMHO, is in fine shape. If he comes back with some real material I might be interested in a look (and I do mean maybe) ABT is in great shape and not under and kind of special investigation or it would be making headline news.
There is no specific problem with the FDA at Abbott. The FDA is in one of our plants every few months just as they are at Lilly, Merck,etc.They are always auditing our records and looking at our process documentation. Abbott's internal auditors do the same on a constant basis, this prepares each plant and/or division for the FDA apperance. Do we make mistakes of course but 99.99% are minor.
I'm always willing to look at new material, provided it's more literate and rational than what NO_ACAMPORA gave us. Chances are good he's trying to short the stock, but it's amazing if he thinks it might work with this one.